Mindray Medical International Limited 

(Public, NYSE:MR)   Watch this stock   
Find more results for MR
Nov 29, 2009
Mindray Medical International LTD at Radiological Society of North America Annual Meeting - 1:00PM EST - Add to calendar
Nov 10, 2009
Q3 2009 Mindray Medical International LTD Earnings Conference Call - Webcast
Nov 9, 2009
Q3 2009 MINDRAY MEDICAL INTL LTD Earnings Release
Sep 22, 2009
MINDRAY MEDICAL INTL LTD at CLSA Investors Forum - Hong Kong
Sep 16, 2009
MINDRAY MEDICAL INTL LTD at Susquehanna International Group Beijing Management Summit
Sep 14, 2009
MINDRAY MEDICAL INTL LTD at Morgan Stanley Global Healthcare Unplugged Conference
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 28.73% 19.85%
Operating margin 22.65% 21.46%
EBITD margin - 25.45%
Return on average assets 19.73% 17.38%
Return on average equity 30.47% 24.50%
Employees 5,760 -

Address

Mindray Building Keji 12th Road South Hi-tech Industrial Park
Nanshan, SHZ 518057
China
+86-755-26582888 (Phone)
+86-755-26582500 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Mindray Medical International Limited discussed on blogs

Mindray Medical International Limited discussions

  View all discussions »

Description

Mindray Medical International Limited (Mindray) is a developer, manufacturer and marketer of medical devices. The Company offers a range of products across its three primary business segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. It sells its products primarily to distributors, and the balance directly to hospitals, clinics, government agencies, original design manufacturer (ODM) customers and original equipment manufacturer (OEM) customers. Outside China the Company sells its products through distributors and its direct sales personnel. In May 2008, the Company completed the acquisition of the patient monitoring business of Datascope Corp.

Officers and directors

Hang Xu
Chairman of the Board, Co-Chief Executive Officer
Age: 46
Bio & Compensation - Reuters
Xiting Li
President, Co-Chief Executive Officer, Director
Age: 57
Bio & Compensation - Reuters
Ronald Ede
Chief Financial Officer, Group Vice President - International Affairs, Director
Age: 50
Bio & Compensation - Reuters
David A. Gibson
President - Datascope Patient Monitoring of Mindray DS USA Corp.
Age: 40
Bio & Compensation - Reuters
Jie Liu
Chief Operating Officer
Age: 40
Bio & Compensation - Reuters
Minghe Cheng
Executive Vice President - Strategic Development
Age: 47
Bio & Compensation - Reuters
Tim Fitzpatrick
General Counsel
Age: 42
Bio & Compensation - Reuters
I-Yin Hsu
Director
Age: 34
Bio & Compensation - Reuters
Qingtai Chen
Director
Age: 71
Bio & Compensation - Reuters
Qiyao Wu
Director
Age: 72
Bio & Compensation - Reuters